BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9373489)

  • 1. An unusual side effect of Dorzolamide.
    Zambarakji HJ; Spencer AF; Vernon SA
    Eye (Lond); 1997; 11 ( Pt 3)():418-9. PubMed ID: 9373489
    [No Abstract]   [Full Text] [Related]  

  • 2. [New drugs in glaucoma therapy].
    Gramer E
    Klin Monbl Augenheilkd; 1998 Jul; 213(1):aA10-2. PubMed ID: 9743931
    [No Abstract]   [Full Text] [Related]  

  • 3. Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects.
    Stewart WC; Day DG; Stewart JA; Holmes KT; Jenkins JN
    Eye (Lond); 2004 Sep; 18(9):905-10. PubMed ID: 15002017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching from dorzolamide to brinzolamide: effect on intraocular pressure and patient comfort.
    Inoue K; Wada SA; Wakakura M; Inoue J; Tomita G
    Jpn J Ophthalmol; 2006; 50(1):68-9. PubMed ID: 16453193
    [No Abstract]   [Full Text] [Related]  

  • 5. Anosmia as an adverse effect of dorzolamid.
    Turgut B; Türkçüoğlu P; Güler M; Akyol N; Celiker U; Demir T
    Acta Ophthalmol Scand; 2007 Mar; 85(2):228-9. PubMed ID: 17305746
    [No Abstract]   [Full Text] [Related]  

  • 6. Dorzolamide-induced choroidal detachment in a surgically untreated eye.
    Goldberg S; Gallily R; Bishara S; Blumenthal EZ
    Am J Ophthalmol; 2004 Aug; 138(2):285-6. PubMed ID: 15289139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual appearance of limbal conjunctival follicles in a patient on brimonidine and dorzolamide.
    Gupta R; Vernon SA
    Eye (Lond); 2005 Mar; 19(3):356-8. PubMed ID: 15286668
    [No Abstract]   [Full Text] [Related]  

  • 8. Refractive change after dorzolamide use in patients with primary open-angle glaucoma and ocular hypertension.
    Tsai JC; Chang HW
    J Ocul Pharmacol Ther; 2001 Dec; 17(6):499-504. PubMed ID: 11777173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The hypotensive action and side effects of the carboanhydrase inhibitor dorzolamide hydrochloride].
    Egorov AE
    Vestn Oftalmol; 1996; 112(2):3-4. PubMed ID: 9045485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated idioventricular rhythm associated to ophthalmic timolol/dorzolamide solution.
    Attanasio A; Baglio S; Quatrana M; Bartorelli L
    Int J Cardiol; 2004 Jun; 95(2-3):343-5. PubMed ID: 15193844
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma.
    Konstas AG; Kozobolis VP; Tersis I; Leech J; Stewart WC
    Eye (Lond); 2003 Jan; 17(1):41-6. PubMed ID: 12579169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].
    Schmidt KG; von Rückmann A; Becker R; Pillunat LE
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anorexia, depression and dementia induced by dorzolamide eyedrops (Trusopt).
    thoe Schwartzenberg GW; Trope GE
    Can J Ophthalmol; 1999 Apr; 34(2):93-4. PubMed ID: 10321320
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical dorzolamide and metabolic acidosis in a neonate.
    Morris S; Geh V; Nischal KK; Sahi S; Ahmed MA
    Br J Ophthalmol; 2003 Aug; 87(8):1052-3. PubMed ID: 12881361
    [No Abstract]   [Full Text] [Related]  

  • 15. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA; Polis A; Ostrov CS; Boyle JE
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K; Snyder E; DuBiner H; Adamsons I
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carbonic anhydrase inhibitors with topical action in the treatment of glaucomatous diseases. A preliminary note].
    Gafencu O; Armegioiu M; Ionita M
    Oftalmologia; 1997; 41(1):66-8. PubMed ID: 9138500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dorzolamide-induced immune thrombocytopenia: a case report and literature review.
    Martin XD; Danese M
    J Glaucoma; 2001 Apr; 10(2):133-5. PubMed ID: 11316096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life.
    Strohmaier K; Snyder E; Adamsons I
    J Am Optom Assoc; 1998 Jul; 69(7):441-51. PubMed ID: 9697378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM; Williams RD; Snyder E; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.